Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Online Network.
Press releases published on August 6, 2025
Anesthesia Respiratory Device Market Anticipated to Achieve 43,823.80 Million USD by 2032 at 8.30% CAGR
EIN Presswire
·
August 6, 2025
Anesthesia Respiratory Device Market is experiencing significant expansion, driven by advancements in patient care technologies, rising surgical procedures NEW YORK, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- The global Anesthesia …
Occupational Health Market Anticipated to Hit USD 62.5 Billion by 2035, Expanding at 4.19% CAGR
EIN Presswire
·
August 6, 2025
Occupational Health Market Research Report By Service Type (Health Screening, Wellness Programs, Occupational Safety Training, Drug Testing, Telehealth Services NEW YORK,, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Occupational Health …
Digestive Health Supplements Market Size & Forecast (2025-2034): USD 25.86 Billion Projection at 6.10% CAGR
EIN Presswire
·
August 6, 2025
The global digestive health supplements market size was worth around USD 14.25 billion in 2024 and is predicted to grow to around USD 25.86 billion by 2034 PUNE, MAHARASHTRA, INDIA, August 6, 2025 /EINPresswire.com/ -- 🔎 Executive Summary The global …
WHX Dubai and WHX Labs Dubai to combine in 2026 to form the world’s largest healthcare event
EIN Presswire
·
August 6, 2025
More than 270,000 professionals from 180 countries and over 4,800 exhibitors will come together in Dubai for one week to shape the industry DUBAI, UNITED ARAB EMIRATES, August 6, 2025 /EINPresswire.com/ -- Informa has announced the launch of the world's …
Cardiovascular Prosthetic Device Market Expected to Surpass USD 123.10 Billion by 2034 with 4.73% CAGR
EIN Presswire
·
August 6, 2025
Cardiovascular Prosthetic Device Market Size, Growth Research Report By Device Type (Heart Valves, Vascular Grafts, Stents, Pacemakers and Defibrillators) NEW YORK,, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Cardiovascular Prosthetic …
Spine Surgery Devices Market to Reach USD 16.2 Billion by 2032, Growing at a CAGR of 3.62%
EIN Presswire
·
August 6, 2025
Spine Surgery Devices Market Size, Growth Research Report By Product Type (Artificial Disc, Fusion Devices, Surgery Accessories, Spine Stimulators) NEW YORK,, NY, UNITED STATES, August 6, 2025 /EINPresswire.com/ -- Spine Surgery Devices Market Overview …
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 6, 2025
MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire
·
August 6, 2025
SEATTLE, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has commenced an underwritten public offering of $75.0 …
STERIS Announces Chief Financial Officer Transition
GlobeNewswire
·
August 6, 2025
Long-time CFO Michael J. Tokich to be succeeded by Karen L. Burton, Chief Accounting Officer DUBLIN, IRELAND, Aug. 06, 2025 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Michael J. Tokich, Senior Vice …
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
GlobeNewswire
·
August 6, 2025
Safety Review Committee endorses escalation to 160 mg TUS dosing Cohorts with 120 mg, 80 mg, 40 mg TUS dosing completed with no dose-limiting toxicities Excellent safety and complete remissions (CRs) in some of the most difficult-to-treat AML populations …
BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire
·
August 6, 2025
Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of proprietary oral small molecules Strengthened discovery …
Surrozen to Present at Upcoming Healthcare Investor Conference
GlobeNewswire
·
August 6, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway for tissue repair and …
STERIS Announces Financial Results for Fiscal 2026 First Quarter
GlobeNewswire
·
August 6, 2025
Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.79; adjusted EPS increased to $2.34 Fiscal 2026 revenue and free cash flow outlook updated DUBLIN, …
Tenaya Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 6, 2025
Enrollment Complete in Cohorts 1 and 2 of MyPEAK™-1 Phase 1b/2 Trial of TN-201 for MYBPC3-associated HCM; Positive DSMB Safety Review Enables Enrollment of Expansion Cohorts Cohort 1 of RIDGE™-1 Phase 1b Trial of TN-401 Enrolled and First PKP2-associated …
Miss Malaysia 2025 Jesreena Kaur Appointed as ScolioLife® Ambassador for Malaysia Launch
EIN Presswire
·
August 6, 2025
Jesreena Kaur Named ScolioLife® Ambassador for Launch of First Scoliosis Clinic in Malaysia MID VALLEY, KUALA LUMPUR, MALAYSIA, August 6, 2025 /EINPresswire.com/ -- ScolioLife®, a global provider of non-surgical scoliosis care, has announced the …
Sanjivani Ayurveda in Vadodara Announces Root-Cause Ayurvedic Approach to Chronic Disease Management
EIN Presswire
·
August 6, 2025
Sanjivani Ayurveda is helping patients overcome chronic and 'incurable' illnesses through personalized, root-cause Ayurvedic treatments. VADODARA, GUJARAT, INDIA, August 6, 2025 /EINPresswire.com/ -- In an era dominated by quick fixes and symptom-based …
Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 6, 2025
Announces positive data for rosnilimab, a pathogenic T cell depleter, through Week 38 from Phase 2b rheumatoid arthritis trial Enrollment completed for rosnilimab Phase 2 ulcerative colitis trial; Top-line data through Week 12 on track for Q4 2025 Ongoing …
DLH Reports Fiscal 2025 Third Quarter Results
GlobeNewswire
·
August 6, 2025
ATLANTA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to …
Keros to Exclusively Prioritize the Clinical Advancement of KER-065
GlobeNewswire
·
August 6, 2025
Company Discontinuing Development of Cibotercept (KER-012) Announces Board and Leadership Changes Designed to Support Streamlined Operational Structure and Strategic Realignment LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. …
Certara Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
August 6, 2025
RADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025. Second Quarter Highlights: Revenue was $104.6 …